An intranasally- and intramuscularly-deliverable nanostructured lipid carrier-replicon RNA vaccine drives protective systemic and mucosal immunity. - McClary WD; Brandt DS; Jennewein MF; Singh J; Beaver S; Ykema MR; Press C; Melief E; Bakken J; Fusco P; Lo E; Battisti P; et al. (Journal of controlled release : official journal of the Controlled Release Society, 2025)